Lexitas is a full-service ophthalmic focused biopharmaceutical solutions company focused on providing end-to-end eyecare support and exceptional service to our clients.
We are keenly focused on building and maintaining collaborative, long-term relationships with our clients, investigators, vendors, partners and employees. Our vision is to be the best ophthalmology solutions company to work with and work for.
Since 2011, Lexitas has provided solutions including clinical trial and medical strategy services to pharmaceutical and biotechnology companies that are developing ophthalmology products. Located in Durham, North Carolina, Lexitas provides end-to-end support and development expertise in ophthalmology.
Lexitas has significant expertise in both anterior and posterior segments of ophthalmology including: dry eye syndrome, meibomian gland dysfunction, blepharitis , bacterial, viral, and allergic conjunctivitis, glaucoma, macular degeneration and diabetic macular edema.